Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65,800.00% | 199,800.00% | 1,227.36% | -33.33% | 100.00% |
| Total Receivables | -38.37% | -44.41% | -52.67% | -11.74% | 61.46% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8,500.00% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 551.64% | 637.35% | 533.73% | -11.78% | -13.88% |
|
|
|||||
| Total Current Assets | 551.64% | 637.35% | 533.73% | -11.78% | -13.88% |
| Net Property, Plant & Equipment | -94.39% | -94.08% | -2.42% | -2.07% | 2.15% |
| Long-term Investments | -- | -- | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.24% | -5.88% | -5.80% | -5.71% | -5.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -54.80% | -54.54% | 3.58% | -4.07% | -4.20% |
|
|
|||||
| Total Accounts Payable | -39.88% | -14.30% | 110.29% | 227.57% | 450.00% |
| Total Accrued Expenses | 361.70% | -15.65% | 1,600.00% | -- | -6.00% |
| Short-term Debt | -28.51% | -26.76% | -- | 14.45% | 16.16% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -28.03% | -25.51% | -90.72% | 20.27% | 23.24% |
|
|
|||||
| Total Current Liabilities | -28.03% | -25.51% | -90.72% | 20.27% | 23.24% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -28.51% | -26.76% | -- | 14.45% | 16.16% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.02% | 1.02% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -22.53% | -20.27% | -20.37% | 15.98% | 18.05% |
|
|
|||||
| Common Stock & APIC | 12.06% | 9.82% | 9.60% | -0.16% | -0.16% |
| Retained Earnings | -179.65% | -190.63% | 9.49% | -40.19% | -50.00% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -84.37% | -83.31% | 18.00% | -15.59% | -16.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | -84.37% | -83.31% | 18.00% | -15.59% | -16.27% |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
| Total Minority Interest | -1.23% | -2.04% | -2.05% | -2.34% | 2.91% |
| Total Equity | -75.02% | -74.39% | 16.13% | -14.07% | -14.32% |
|
|
|||||